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Abstract. Main secondary metabolites identified in species of genus Bryoria are 
fumarprotocetraric and confumarprotocetraric acids, followed by stictic and lobaric 
acids, atranorin, gyrophoric, vulpinic, barbatolic and usnic acids. This review deals 
with the antimicrobial activity of substances identified from the genus Bryoria. These 
data may be useful in predicting the activity of extracts if their composition is known. 
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1. INTRODUCTION 
For a long time, some lichen species have been used in traditional medicine in the 
treatment of numerous infectious diseases (Bown, 2001). The use of lichens in medicine 
is based on the fact that they contain unique and varied biologically active substances. 
Lichen substances exert a wide variety of biological actions including antibiotic, 
antimycotic, antiviral, anti-inflammatory, analgesic, antipyretic, antiproliferative and 
cytotoxic effects (Kosanić et al., 2012; Manojlović et al., 2010; Stojanović et al., 2012). 
Metabolites synthesized by lichens are divided into two groups: primary (intracellular) 
and secondary (extracellular). Primary metabolites are mainly the same substances as in 
other plants, and they have structural functions and roles in cellular metabolism (Podterob, 
2008). Primary metabolites include amino acids, vitamins, enzymes, disaccharides, chitin (in 
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hyphal walls), lichenin, isolichenin, hemicellulose, pectins, polyalcohols, pigments 
(chlorophylls a and b, b- and γ-carotenes, xanthophylls), etc. (Podterob, 2008). 
The majority of organic compounds found in lichens are secondary metabolites. Lichens 
may contain substantial amounts of secondary metabolites, usually between 0.1 and 10 % of 
the dry weight of the thallus, but sometimes up to 30 % (Galun and Shomer-Ilan, 1988; 
Stocker-Wörgötter, 2008; Solhaug et al., 2009). They are poorly soluble in water and can 
usually be isolated from lichen by organic solvents (Otzurk et al., 1999). More than one 
hundred secondary metabolites, mainly monoaromatics, depsides, depsidones, pulvinates, 
dibenzofurans, anthraquinones and xanthones, characteristic for lichen, have been detected 
and isolated (Molnar and Farkaš, 2010). Chemicals structures of these classes of compounds 
are similar and identification is often very difficult. 
Lichen acids, which is a common name for secondary metabolites, are produced 
primarily by the mycobiont. Secondary metabolites are deposited externally on the hyphae of 
the cortex and/or medulla (Boustie and Grube, 2005).  
Lichen acids are derived from three chemical pathways: acetate-polymalonate pathway, 
shikimic acid pathway and, mevalonic acid pathway. The acetate-polymalonate pathway 
includes the most common lichens compounds such as: aliphatic acids, esters, and related 
derivates, mononuclear phenolic compounds, depsides, depsidones, depsones, dibenzofuranes, 
anthraquinones, chromones, naphthoquinones, and xanthones. The shikimic acid pathway 
includes pulvinic acid derivatives (yellow pigments) and terphenylquinones. The mevalonic 
acid pathway includes di-, sester- and triterpenes and steroids. 
Apart from compounds derived from these pathways, which are found throughout all 
major lichen groups, there are also some unusual compounds classes among these 
organisms, for example, arthogalin, a cycle depsipeptide (Huneek and Himmelreich, 1995) 
and other amino acids derived from compound such as the cytotoxic scabrosin esters isolated 
from Xanthoparelia scabrosa (Ernst-Russel et al., 1999). The most common phenolic acid 
units derived by the acetate-polymalonate pathway and combined to the characteristic lichen 
substances are of two types: the orcinol type units and β-orcinol type units. While 
compounds formed from these two types of units are similar in many ways, differences in 
their structure, especially in their distribution among the lichens, suggest that the usual 
tendency to consider the ornicol and β-ornicol compounds separately probably has a 
biosynthetic justification. Derivatives of orcinol and ß-orcinol units include depsides, 
depsidones, depsones, anthraquinones, and xanthones. 
Bryoria belongs to the genus of lichen within the Parmeliaceae family, and it contains 51 
species. This genus has a widespread distribution, especially in boreal and moderate climatic 
areas (Kirk et al., 2008). They usually grow on sun-exposed sites, on tree branches and near 
the water or on branches hanging over brooks (Lukáč, 2009). 
Secondary metabolites identified in most of the species of genus Bryoria are 
fumarprotocetraric and confumarprotocetraric acid. Those two lichen acids are considered to 
be the main components of the species in the genus Bryoria. Along with fumarprotocetraric 
acid and confumarprotocetraric acid, stictic acid, lobaric acid, atranorin, gyrophoric acid, 
vulpinic acid, barbatolic acid, and usnic acid have been identified (Myllys et al., 2011). 
The aim of this work is to present the antimicrobial activity of secondary metabolites 
identified in species of the genus Bryoria in order to predict the antimicrobial potential of 
extracts of the genus Bryoria. 
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2. ANTIMICROBIAL ACTIVITY  
The structures and antimicrobial activity of the compounds identified from the species 
of the genus Bryoria are given in Figure 1 and Tables 1 and 2. Fumarprotocetraric acid 
(sometimes misspelled fumaroprotocetraric acid) is present in almost all species of genus 
Bryoria as the main component. This acid is also specific for Cladonia species (Myllys et 
al., 2011). This acid shows higher antimicrobial activity in comparison with protocetraric 
acid, stictic acid (Ranković and Mišić, 2008) and atranorin, but considerably weaker than 
(+)-usnic acid (see Table 1) (Yılmaza et al., 2004). Strong antimicrobial activity of 
fumarprotocetraric acid isolated from Cladonia foliacae is confirmed by Yilmaz et al. 
(2004). Fumarprotocetraric acid shows better antibacterial than antifungal activity as most 
of the lichen secondary metabolites (Ranković and Mišić, 2008). There are no data on the 






















Fig. 1 Structures of the identified acids from the species of the genus Bryoria 
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Table 1 Minimal inhibitory concentrations (MIC) of the isolated lichen compounds 
TEST ORGANISM FUM PRO STI GYR ATR LOB NOR (+)-USN S K 
B. mycoides 0.062a 0.062a 
0.015b 
0.5a 0.125c 0.031c NS NS 0.0075c 
0.0008b 
7.81 / 
B. subtilis 0.062a 
0.0046e 
0.062a 
0.015b    -
-f 
0.5a 0.25c 0.031c 
0.0156e 




E. cloaceae 0.062a 0.062a 0.5a 0.25c 0.031c NS NS 0.015c 1.95 / 
E. coli 0.062a 0.125a 1b               
--f 
0.5a 0.25c 0.031c NS --f 0.031c 
0.25b          
--f 
31.25 / 
K. pneumoniae 0.031a 0.062a 
0.5b          -
-f 
0.25a 0.25c 0.031c NS --f 0.0037c 
0.0625b       
--f 
1.95 / 
S. aureus 0.062a 
0.0375e 
0.125a 
0.015b    -
-f 
0.5a 0.25c 0.031c 
0.5e 




A. flavus 0.25a 0.125a 1b 1a 0.5c 0.5c NS NS 0.5c           
0.5b 
/ 3.9 
A. fumigatus 0.25a 0.125a 
0.25b 
1a 0.25c 0.25c NS NS 0.5c       
0.25b 
/ 3.9 
B. cinerea 0.125a 0.062a 0.5a 0.25c 0.25c NS NS 0.25c / 1.95 










F. oxysporum 0.25a 0.125a 1a 0.25c 0.5c NS NS 0.5c / 3.9 
M. mucedo 0.25a 0.125a 1a 0.25c 0.5c NS NS 0.5c / 31.25 
P. variotii 0.125a 0.062a 0.5a 0.25c 0.25c NS NS --c / 1.95 
P. purpurescens 0.25a 0.125a 1b 1a 0.5c 0.5c NS NS 0.25c       
0.5b 
/ 3.9 
P. verrucosum 0.25a 0.125a 
0.5b 
1a 0.5c 0.25c NS NS 0.5c           
0.5b 
/ 3.9 
T.harsianum 0.25a 0.125a 1a 0.25c 0.25c NS NS 0.5c / 7.81 
M. aurum NS NS NS NS 0.25d 0.125d NS 0.032d NS NS 
B. cereus 0.0046e --f NS NS 0.0312e NS --f --a                      
--f 
NS NS 
P. vulgaris 0.0375e --f NS NS 0.0625e NS 0.6253f 0.01248f NS NS 
A. hydrophila 0.15e --f NS NS 0.0312e NS 0.312f --f NS NS 
S. faecalis 0.15e --f NS NS 0.25e NS 0.312f 0.0256f NS NS 
L. monocytogenes 0.0046e --f NS NS 0.156e NS 0.156f 0.00624f NS NS 
C. glabrata 0.0187e 0.052c 
0.052f 
NS NS 0.5e NS 0.0386f 0.0008f NS NS 
P. aeruginosa NS --c              
--f 
NS NS NS NS --f --f NS NS 
P. syringae NS --c              
--f 
NS NS NS NS --f --f NS NS 
S. typhimurium NS --c              
--f 
NS NS NS NS --f --f NS NS 
Y. enterocolitica NS --c              
--f 
NS NS NS NS --f 0.00624f NS NS 
Values given as mg/mL for lichen compounds and as µg/mL for antibiotics S- Streptomycin, K- Ketaconazole; -- inactive compound; NS- 
data not shown; FUM- fumarprotocetraric acid; PRO- protocetraric acid; STI- stictic acid; GYR- gyrophoric acid; ATR- atranorin; LOB-
lobaric acid; NOR- norstictic acid; (+)USN- usnic acid; 
a
lichen compound PRO isolated from Parmelia caperata, STI isolated from 
Parmelia consperesa, and FUM isolated from Cladonia furcate (Ranković and Mišić, 2008); blichen compound PRO isolated from 
Toninia candida and (+)USN isolated from Evernia prunastri (Manojlović et al., 2012); clichen compound GYR isolated from Umbiica 
riapolyphylla, ATR isolated from Physcia aipolia and (+)USN isolated from Parmelia caperata (Ranković et al., 2008); dlichen 
compound LOB isolated from Stereocaulon alpinum, (+)USN isolated from Cladonia arbuscula (Ingólfsdóttir et al.,1998); 
e
lichen 
compounds isolated from Cladonia foliacea (Yılmaza et al., 2004); flichen compounds isolated from Ramalina farinacea (Tay et al., 
2004).
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Atranorin is a para-depside present in the lichens Bryoria nadvornikiana, B. trichodes, 
B. implexa rarely in lichens B. capillaris and B. lanestris (Myllys et al., 2011). According 
to literature data, atranorin, in general, shows weak antimicrobial activity. In comparison 
with fumarprotocentraric acid, where both of those components are isolated from C. 
foliacea, atranorin shows much weaker antimicrobial activity, even up to 26 times lower 
for some microorganisms (Yılmaza et al., 2004). Perry et al., (1999) presented inactivity 
of atranorin against Bacillus subtilis, Trichophyton mentagrophyte and Candida albicans 
which was not in accordance with the results of Clavalcanti et al., (1983). Saenza et al. 
(2006) showed atranorin’s inactivity to all tested organisms except towards the extremely 
sensitive bacteria K. pneumonia for which atranorin shows weak activity. Atranorin 
shows similar antimicrobial activity as salazinic acid against Mycobacterium aurum. 
Japanese studies (Shibata and Miura, 1948) were found those components to be inactive 
against Mycobacterium tuberculosis (see Table 1) (Ingólfsdóttir et al., 1998). 
Gyrophoric acid is a tridepside which shows antimicrobial activity toward 16 
microorganisms tested by Ranković et al., (2008). Gyrophoric acid antibacterial activity is 
slightly weaker than atranorin and significantly weaker than (+)-usnic acid, while the 
antifungal activity is very similar for all three components (see Table 1) (Ranković et al., 
2008).  
Stictic acid is identified only in species B. nadvornikiana S 294 (Myllys et al., 2011). 
Stictic acid shows weaker antimicrobial activity in comparison with fumarprotocetraric 
acid and protocetraric acid regarding all microorganisms tested by Ranković and Mišić, 
(2008) and Saenza et al., (2006) (see Table 1). Perry et al., (1999) reported inactivity of 
stictic acid against all microorganisms which they tested. 
Norstictic acid is found in B. implexa (Myllys et al., 2011) and shows weak or lack 
antimicrobial activity (Tay et al., 2004). 
Vulpinic acid is diphenyl-butenolide, mostly yellow or orange pigment which protects 
lichens from UV light. B. fremontii is the only one in the genus Bryoria producing 
vulpinic acid (Myllys et al., 2011). Lauterwein et al., (1995) showed that (+)-usnic acid, (-
)-usnic acid, and vulpinic acid did not inhibit Gram-negative rods or fungi at 
concentrations lower than 32 μg/mL but were active against clinical isolates of 
Enterococcus faecalis, Enterococcus faecium, and Staphylococcus aureus.  
Protocetraric acid is present in almost every species of the genus Brioria (except B. 
capillaris, B. fremontii and B. glabra), but in some species, it is present in small amounts. 
Protocetraric acid showed similar antibacterial activity as fumarprotocetraric acid and 
lecanoric acid (Tay et al., 2004; Ranković and Mišić, 2008). Manojlović et al., (2012) 
presented a similar antimicrobial activity of protocetraric acid and salazinic acid, as well 
as Yang and Anderson, (1999) and Kosanić et al., (2012).  
Lobaric acid is rarely present in the genus Bryoria. Myllys et al., (2011) found lobaric 
acid in B. perspinosa S296. Lobaric acid showed stronger antimicrobial activity than 
atranorin and salazinic acid, but weaker than (+)-usnic acid against bacteria M. aurum 
(see Table 1) (Ingólfsdóttir et al., 1998).
 
Usnic acid is the most widely used lichen acid in medicine; this is a crystalline 
substance with a yellow color (Moiseeva et al., 1961). Usnic acid is optically active and 
both forms are found in lichens from 0.2% (Cladonia sylvatica) to 4.0% (Alectoria 
achroleuca). In species of the genus Bryoria, usnic acid is not identified, except in B. 
hengduanensis S287 (Myllys et al., 2011). Usnic acid showed the strongest antibacterial 
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activity from all tested lichen secondary metabolites (see Table 1) (Saenza et al., 2006; 
Perry et al., 1999; Tay et al., 2004; Manojlović et al., 2012; Ingólfsdóttir et al., 1998; 
Ranković et al., 2008; Lauterwein et al., 1995). 
3. CONCLUSIONS 
Fumarprotocetraric acid and confumarprotocetraric acid are identified in most of the 
species of genus Bryoria as main components.  It has been proven that fumarprotocetraric 
acid shows antimicrobial activity of medium strength. Other lichen acids identified in the 
species of genus Bryoria (protocetraric acid, stictic acid, lobaric acid, atranorin, gyrophoric 
acid) show weaker antimicrobial activity in comparison to fumarprotocetraric acids. 
Secondary metabolites which are present in genus Bryoria, show higher antibacterial than 
antifungal activity. Considering manifested activity of Bryoria constituents, one might 
expect that extracts could exhibit a moderate antimicrobial activity wherein the higher 
antibacterial than antifungal. This statement is true if there is no synergistic or antagonistic 
effect among the extracts constituents. Some components that are represented in a small 
amount may have a high activity and/or synergistic influence. Therefore, it is not enough to 
identify only the main components for the evaluation of the activity. 
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ANTIMIKROBNA AKTIVNOST JEDINJENJA 
IDENTIFIKOVANIH U VRSTAMA RODA BRYORIA – 
PREGLEDNI RAD 
Glavni sekundarni metaboliti koji su identifikovani u vrstama roda Bryoria su fumarprotocetrarična 
kiselina i konfumarprotocetrarična kiselina, praćene stiktičnom kiselinom, lobarnom kiselinom, 
atranorinom, girofornom kiselinom, vulpinskom, barbatoličnom kiselinom i usninskom kiselinom. U 
ovom preglednom članku data je analiza antimikrobne aktivnosti sastojaka identifikovanih u vrstama 
roda Bryoria. Ovaj pregledni članak može biti od koristi za predviđanje antimikrobne aktivnost 
ekstrakata poznatog sastava. 
Ključne reči: antimikrobna aktivnost, Bryoria, konfumarprotocetrarična kiselina, 
fumarprotocetrarična kiselina, lišajske kiseline 
